Navigation Links
QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
Date:1/9/2012

ed testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the first FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics. As of September 30, 2011, QIAGEN employed approximately 3,800 people in over 35 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/.

Certain of the statements contained in this news release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements contained herein relating to QIAGEN's products, markets, strategy or operating results, including without limitation its expected operating results, are forward-looking, such statements are based on current expectations and assumptions that involve a number of uncertainties and risks. Such uncertainties and risks include, but are not limited to, risks associated with management of growth and international operations (including the effects of currency fluctuations, regulatory processes and dependence on logistics), variability of operating results and allocations between customer classes, the commercial development of markets for our products in applied testing, personalized healthcare, clinical research, proteomics, women's health/HPV testing and nucleic acid-based molecular diagnostics; changing relationships with customers, suppliers and strategic partners; competition; rapid or unexpected changes in technologies; fluctuations in demand for QIAGEN's products (including fluctuations due to general economic conditions, the level
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
2. QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV
3. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. QIAGEN Acquires Exclusive Licence for Key PI3K gene
6. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
7. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
8. Plexus Awarded Development Contract With QIAGEN
9. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
10. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
11. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Israel , June 18, 2013 ... Ingredients (APIs), generic and innovative intermediates, and finished dosage forms ... company has been granted a United States ... and Europe for the oral treatment ... B2 is titled Intermediate Compounds and Processes for the ...
(Date:6/18/2013)... Texas , June 18, 2013   ... ), a biopharmaceutical company focused on discovering breakthrough ... John Northcott has joined the company as ... operations. Mr. Northcott brings extensive commercial experience to ... across a variety of therapeutic areas. ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
(Date:6/18/2013)... Park City, UT (PRWEB) June 18, 2013 ... developing next generation imaging and in vitro diagnostic (IVD) ... study with NuView’s novel urine screen in development for ... The study was presented in an oral presentation at ... Medicine and Molecular Imaging (SNMMI) in Vancouver, Canada on ...
Breaking Biology Technology:Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3
... the Georgia Institute of Technology have made important findings ... an electrical field on a surface-supported gold nanocluster changes ... flat structure. In another paper, they relate their discovery ... magnetic through oxygenation of gold nanowires. They also found ...
... ETEX Corporation, an advanced,biomaterials company, announced today that ... Health, Inc., Under the agreement, LifeNet Health ... to be mixed with ETEX,s proprietary,calcium phosphate to ... will manufacture EquivaBone(TM) in its Cambridge,facilities and market ...
... IOMI ) today announced that it will release fourth ... and hold a,conference call and live webcast to discuss ... 1:30 p.m. Eastern Time., Conference Call Details, ... 6 at 1:30 p.m.,Eastern Time via phone, please dial ...
Cached Biology Technology:Physicists discover gold can be magnetic on the nanoscale 2Physicists discover gold can be magnetic on the nanoscale 3Physicists discover gold can be magnetic on the nanoscale 4ETEX and LifeNet Health, Inc. Enter Agreement 2Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6 2
(Date:6/17/2013)... research associate has received a prestigious fellowship to support ... spread of malaria. , Bart Bryant, research associate in ... Research Service Award Individual Postdoctoral Fellowship, which provides $113,000 ... University researcher to receive the award and is the ... award. , Bryant, a university doctoral graduate in biology, ...
(Date:6/17/2013)... method of mining shale gas, is widespread across Pennsylvania, ... New research in the Annals of the New ... to biodiversity including pollution from toxic chemicals, the building ... , "Shale gas has engendered a great deal of ... but effects on biological diversity and resources have scarcely ...
(Date:6/16/2013)... together and move around the body called ,chase and ... scientists at UCL. , Published in Nature Cell ... occurs when cancer cells interact with healthy cells in order ... cancer cells recruit healthy cells and use them to travel ... it could be controlled to design new therapies against cancer ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2'Chase and run' cell movement mechanism explains process of metastasis 2
... 17, 2009 -- Burnham Institute for Medical Research (Burnham) ... fellows will present seven papers on their data at ... Meeting 2009. In addition, John C. Reed, M.D., Ph.D., ... Chair, will chair a panel on Apoptosis-based Strategies for ...
... New studies indicate the three drugs used to treat ... little differently, and should give the scientific community pause to ... percent of women who report sexual dysfunction, researchers say. ... phosphodiesterase Type 5 inhibitors - Viagra, Levitra and Cialis - ...
... yet its effect on their body composition and exercise performance ... now examined the effects of OC on female muscle mass, ... young women, and is associated with lower hormone levels. ... Oral Contraceptive Use Impairs Muscle Gains in Young Women. It ...
Cached Biology News:Male impotence drugs may deserve a second look in women 2Male impotence drugs may deserve a second look in women 3Oral contraceptives impair muscle gains in young women 2
MAb to Desmoplakin I & II Desmoplakin I & II...
BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes...
... ICE-family proteases/caspases initiates apoptosis in mammalian cells. ... Kit provides a simple and convenient means ... cytometry in intact cells. The assay ... residues linked to rhodamine 110 (D2R), a ...
... antibiotic-based selection system for recombinant identification. Recombinant ... the need for costly color screening. This ... 100% accuracy in recombinant selection. pLivSelect is ... picking. This cloning kit can be used ...
Biology Products: